Bank of America’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.5K | Sell |
5,240
-122
| -2% | -$1.11K | ﹤0.01% | 5833 |
|
|
2025
Q1 | $51.2K | Sell |
5,362
-1,900
| -26% | -$18.1K | ﹤0.01% | 5729 |
|
|
2024
Q4 | $81.6K | Buy |
7,262
+1,322
| +22% | +$14.8K | ﹤0.01% | 5599 |
|
|
2024
Q3 | $85.4K | Sell |
5,940
-388
| -6% | -$5.58K | ﹤0.01% | 5511 |
|
|
2024
Q2 | $109K | Buy |
6,328
+693
| +12% | +$12K | ﹤0.01% | 5390 |
|
|
2024
Q1 | $112K | Buy |
5,635
+793
| +16% | +$15.8K | ﹤0.01% | 5341 |
|
|
2023
Q4 | $50.9K | Buy |
4,842
+1,473
| +44% | +$15.5K | ﹤0.01% | 5660 |
|
|
2023
Q3 | $29.8K | Sell |
3,369
-1,691
| -33% | -$14.9K | ﹤0.01% | 5729 |
|
|
2023
Q2 | $48.8K | Sell |
5,060
-703
| -12% | -$6.78K | ﹤0.01% | 5612 |
|
|
2023
Q1 | $79.5K | Sell |
5,763
-3,647
| -39% | -$50.3K | ﹤0.01% | 5545 |
|
|
2022
Q4 | $143K | Sell |
9,410
-6,651
| -41% | -$101K | ﹤0.01% | 5352 |
|
|
2022
Q3 | $146K | Buy |
16,061
+5,416
| +51% | +$49.2K | ﹤0.01% | 5347 |
|
|
2022
Q2 | $90K | Buy |
10,645
+4,432
| +71% | +$37.5K | ﹤0.01% | 5752 |
|
|
2022
Q1 | $122K | Buy |
6,213
+3,110
| +100% | +$61.1K | ﹤0.01% | 5978 |
|
|
2021
Q4 | $76K | Buy |
3,103
+1,152
| +59% | +$28.2K | ﹤0.01% | 6170 |
|
|
2021
Q3 | $76K | Buy |
1,951
+1,181
| +153% | +$46K | ﹤0.01% | 5980 |
|
|
2021
Q2 | $35K | Buy |
770
+397
| +106% | +$18K | ﹤0.01% | 6152 |
|
|
2021
Q1 | $13K | Sell |
373
-1,724
| -82% | -$60.1K | ﹤0.01% | 6253 |
|
|
2020
Q4 | $76K | Buy |
+2,097
| New | +$76K | ﹤0.01% | 5381 |
|